<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36695658</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Inhibition of PIKFYVE kinase interferes ESCRT pathway to suppress RNA virus replication.</ArticleTitle><Pagination><StartPage>e28527</StartPage><MedlinePgn>e28527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.28527</ELocationID><Abstract><AbstractText>Endosomal sorting complex required for transport (ESCRT) is essential in the functional operation of endosomal transport in envelopment and budding of enveloped RNA viruses. However, in nonenveloped RNA viruses such as enteroviruses of the Picornaviridae family, the precise function of ESCRT pathway in viral replication remains elusive. Here, we initially evaluated that the&#xa0;ESCRT pathway is important for viral replication upon enterovirus 71 (EV71) infection. Furthermore, we discovered that YM201636, a specific inhibitor of phosphoinositide kinase, FYVE finger containing (PIKFYVE) kinase, significantly suppressed EV71 replication and virus-induced inflammation in vitro and in vivo. Mechanistically, YM201636 inhibits PIKFYVE kinase to block the&#xa0;ESCRT pathway and endosomal transport, leading to the disruption of viral entry and replication complex in subcellular components and ultimately repression of intracellular RNA virus replication and virus-induced inflammatory responses. Further studies found that YM201636 broadly represses the replication of other RNA viruses, including coxsackievirus B3 (CVB3), poliovirus 1 (PV1), echovirus 11 (E11), Zika virus (ZIKV), and vesicular stomatitis virus (VSV), rather than DNA viruses, including adenovirus 3 (ADV3) and hepatitis B virus (HBV). Our findings shed light on the mechanism underlying PIKFYVE-modulated ESCRT pathway involved in RNA virus replication, and also provide a prospective antiviral therapy during RNA viruses infections.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foshan Institute of Medical Microbiology, Foshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yicong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Mingfu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Zhihui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foshan Institute of Medical Microbiology, Foshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Key Laboratory of Immunology and Targeted Drug, School of Basic Medical Science, Xinxiang Medical University, Xinxiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shereen</LastName><ForeName>Muhammad Adnan</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Kohsar University Murree, Kashmir Point, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Jialing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kailang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qiwei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foshan Institute of Medical Microbiology, Foshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yongkui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foshan Institute of Medical Microbiology, Foshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jianguo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foshan Institute of Medical Microbiology, Foshan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C540576">6-amino-N-(3-(4-(4-morpholinyl)pyrido(3',2'-4,5)furo(3,2-d)pyrimidin-2-yl)phenyl)-3-pyridinecarboxamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056827">Endosomal Sorting Complexes Required for Transport</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.137</RegistryNumber><NameOfSubstance UI="C492139">PIKFYVE protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="Y">Zika Virus Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="Y">Zika Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056827" MajorTopicYN="N">Endosomal Sorting Complexes Required for Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA virus replication</Keyword><Keyword MajorTopicYN="N">antiviral therapy</Keyword><Keyword MajorTopicYN="N">endosomal sorting complex required for transport (ESCRT)</Keyword><Keyword MajorTopicYN="N">enveloped RNA viruses</Keyword><Keyword MajorTopicYN="N">nonenveloped RNA viruses</Keyword><Keyword MajorTopicYN="N">phosphoinositide kinase FYVE finger containing (PIKFYVE)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36695658</ArticleId><ArticleId IdType="doi">10.1002/jmv.28527</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Naslavsky N, Caplan S. The enigmatic endosome-sorting the ins and outs of endocytic trafficking. J Cell Sci. 2018;131(13):jcs216499.</Citation></Reference><Reference><Citation>Huotari J, Helenius A. Endosome maturation. EMBO J. 2011;30(17):3481-3500.</Citation></Reference><Reference><Citation>Saftig P, Haas A. Turn up the lysosome. Nature Cell Biol. 2016;18(10):1025-1027.</Citation></Reference><Reference><Citation>Hsu VW, Prekeris R. Transport at the recycling endosome. Curr Opin Cell Biol. 2010;22(4):528-534.</Citation></Reference><Reference><Citation>Henne WM, Buchkovich NJ, Emr SD. The ESCRT pathway. Dev Cell. 2011;21(1):77-91.</Citation></Reference><Reference><Citation>Owusu IA, Quaye O, Passalacqua KD, Wobus CE. Egress of non-enveloped enteric RNA viruses. J Gen Virol. 2021;102(3):001557.</Citation></Reference><Reference><Citation>Velamoor S, Mitchell A, Humbel BM, et al. Visualizing nudivirus assembly and egress. mBio. 2020;11(4):e01333-20.</Citation></Reference><Reference><Citation>Amiar S, Stahelin RV. The Ebola virus matrix protein VP40 hijacks the host plasma membrane to form virus envelope. J Lipid Res. 2020;61(7):971.</Citation></Reference><Reference><Citation>Janvier K, Roy N, Berlioz-Torrent C. Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin. Curr HIV Res. 2012;10(4):315-320.</Citation></Reference><Reference><Citation>Wirblich C, Bhattacharya B, Roy P. Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol. 2006;80(1):460-473.</Citation></Reference><Reference><Citation>Cabrera JR, Manivanh R, North BJ, Leib DA. The ESCRT-related ATPase Vps4 is modulated by interferon during herpes simplex virus 1 infection. mBio. 2019;10(2):e02567-18.</Citation></Reference><Reference><Citation>Arii J, Takeshima K, Maruzuru Y, et al. Role of the arginine cluster in the disordered domain of herpes simplex virus 1 UL34 for the recruitment of ESCRT-III for viral primary envelopment. J Virol. 2022;96(2):e0170421.</Citation></Reference><Reference><Citation>Lambert C, D&#xf6;ring T, Prange R. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and &#x3b3;2-adaptin. J Virol. 2007;81(17):9050-9060.</Citation></Reference><Reference><Citation>Mannemuddhu SS, Xu H, Bleck CKE, Tjandra N, Carter C, Bhaduri-McIntosh S. Prazoles targeting Tsg101 inhibit release of Epstein-Barr virus following reactivation from latency. J Virol. 2021;95(13):e0246620.</Citation></Reference><Reference><Citation>Feng Z, Hensley L, McKnight KL, et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature. 2013;496(7445):367-371.</Citation></Reference><Reference><Citation>Labadie T, Jegouic S, Roy P. Bluetongue virus nonstructural protein 3 orchestrates virus maturation and drives non-lytic egress via two polybasic motifs. Viruses. 2019;11:1107.</Citation></Reference><Reference><Citation>Staring J, von Castelmur E, Blomen VA, et al. PLA2G16 represents a switch between entry and clearance of Picornaviridae. Nature. 2017;541(7637):412-416.</Citation></Reference><Reference><Citation>Chen SL, Liu YG, Zhou YT, et al. Endophilin-A2-mediated endocytic pathway is critical for enterovirus 71 entry into caco-2 cells. Emerg Microbes Infect. 2019;8(1):773-786.</Citation></Reference><Reference><Citation>McKnight KL, Xie L, Gonz&#xe1;lez-L&#xf3;pez O, Rivera-Serrano EE, Chen X, Lemon SM. Protein composition of the hepatitis A virus quasi-envelope. Proc&#xa0;Natl&#xa0;Acad&#xa0;Sci&#xa0;USA. 2017;114(25):6587-6592.</Citation></Reference><Reference><Citation>Karjalainen M, Rintanen N, Lehkonen M, et al. Echovirus 1 infection depends on biogenesis of novel multivesicular bodies. Cell Microbiol. 2011;13(12):1975-1995.</Citation></Reference><Reference><Citation>Ikonomov OC, Sbrissa D, Mlak K, Kanzaki M, Pessin J, Shisheva A. Functional dissection of lipid and protein kinase signals of PIKfyve reveals the role of PtdIns 3,5-P2 production for endomembrane integrity. J Biol Chem. 2002;277(11):9206-9211.</Citation></Reference><Reference><Citation>Xu T, Gan Q, Wu B, et al. Molecular basis for PI(3,5)P2 recognition by SNX11, a protein involved in lysosomal degradation and endosome homeostasis regulation. J Mol Biol. 2020;432(16):4750-4761.</Citation></Reference><Reference><Citation>Ikonomov OC, Sbrissa D, Shisheva A. Mammalian cell morphology and endocytic membrane homeostasis require enzymatically active phosphoinositide 5-kinase PIKfyve. J Biol Chem. 2001;276(28):26141-26147.</Citation></Reference><Reference><Citation>Kim GHE, Dayam RM, Prashar A, Terebiznik M, Botelho RJ. PIKfyve inhibition interferes with phagosome and endosome maturation in macrophages. Traffic. 2014;15(10):1143-1163.</Citation></Reference><Reference><Citation>Jefferies HBJ, Cooke FT, Jat P, et al. A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep. 2008;9(2):164-170.</Citation></Reference><Reference><Citation>Kerr MC, Wang JTH, Castro NA, et al. Inhibition of the PtdIns(5) kinase PIKfyve disrupts intracellular replication of salmonella. EMBO J. 2010;29(8):1331-1347.</Citation></Reference><Reference><Citation>Su R, Shereen MA, Zeng X, et al. The TLR3/IRF1/Type III IFN axis facilitates antiviral responses against enterovirus infections in the intestine. mBio. 2020;11(6):e02540-20.</Citation></Reference><Reference><Citation>Li Y, Huang Y, Pan P, et al. Sericin and sericin-derived peptide alleviate viral pathogenesis in mice though inhibiting lactate production and facilitating antiviral response. Appl&#xa0;Mater&#xa0;Today. 2021;25:101256.</Citation></Reference><Reference><Citation>Zhang W, Yang X, Chen L, et al. A conserved ubiquitin- and ESCRT-dependent pathway internalizes human lysosomal membrane proteins for degradation. PLoS Biol. 2021;19(7):e3001361.</Citation></Reference><Reference><Citation>Chadwick SR, Grinstein S, Freeman SA. From the inside out: ion fluxes at the centre of endocytic traffic. Curr Opin Cell Biol. 2021;71:77-86.</Citation></Reference><Reference><Citation>Hernandez-Gonzalez M, Larocque G, Way M. Viral use and subversion of membrane organization and trafficking. J Cell Sci. 2021;134(5):jcs252676.</Citation></Reference><Reference><Citation>Luo Z, Dong X, Li Y, et al. PolyC-binding protein 1 interacts with 5'-untranslated region of enterovirus 71 RNA in membrane-associated complex to facilitate viral replication. PLoS One. 2014;9(1):e87491.</Citation></Reference><Reference><Citation>Cortese M, Goellner S, Acosta EG, et al. Ultrastructural characterization of zika virus replication factories. Cell Rep. 2017;18(9):2113-2123.</Citation></Reference><Reference><Citation>Klein S, Cortese M, Winter SL, et al. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat Commun. 2020;11(1):5885.</Citation></Reference><Reference><Citation>Li Y, Chang Z, Wu P, et al. Emerging enteroviruses causing hand, foot and mouth disease, China, 2010-2016. Emerging Infect Dis. 2018;24(10):1902-1906.</Citation></Reference><Reference><Citation>Hsu NY, Ilnytska O, Belov G, et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 2010;141(5):799-811.</Citation></Reference><Reference><Citation>Laufman O, Perrino J, Andino R. Viral generated inter-organelle contacts redirect lipid flux for genome replication. Cell. 2019;178(2):275-289.</Citation></Reference><Reference><Citation>Richardson LGL, Clendening EA, Sheen H, Gidda SK, White KA, Mullen RT. A unique N-terminal sequence in the carnation Italian ringspot virus p36 replicase-associated protein interacts with the host cell ESCRT-I component Vps23. J Virol. 2014;88(11):6329-6344.</Citation></Reference><Reference><Citation>Reid C, Airo A, Hobman T. The virus-host interplay: biogenesis of +RNA replication complexes. Viruses. 2015;7(8):4385-4413.</Citation></Reference><Reference><Citation>Denison MR. Seeking membranes: positive-strand RNA virus replication complexes. PLoS Biol. 2008;6(10):e270.</Citation></Reference><Reference><Citation>Neufeldt CJ, Cortese M. Membrane architects: how positive-strand RNA viruses restructure the cell. J Gen Virol. 2022;103(8):001773.</Citation></Reference><Reference><Citation>Wolff G, B&#xe1;rcena M. Multiscale electron microscopy for the study of viral replication organelles. Viruses. 2021;13(2):197.</Citation></Reference><Reference><Citation>Carette JE, Raaben M, Wong AC, et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 2011;477(7364):340-343.</Citation></Reference><Reference><Citation>Kang YL, Chou Y, Rothlauf PW, et al. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proc&#xa0;Natl&#xa0;Acad&#xa0;Sci&#xa0;USA. 2020;117(34):20803-20813.</Citation></Reference><Reference><Citation>Kumar S, Barouch-Bentov R, Xiao F, et al. MARCH8 ubiquitinates the hepatitis C virus nonstructural 2 protein and mediates viral envelopment. Cell Rep. 2019;26(7):1800-1814.</Citation></Reference><Reference><Citation>Soh TK, Whelan SPJ. Tracking the fate of genetically distinct vesicular stomatitis virus matrix proteins highlights the role for late domains in assembly. J Virol. 2015;89(23):11750-11760.</Citation></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182(3):685-712.</Citation></Reference><Reference><Citation>Wang R, Simoneau CR, Kulsuptrakul J, et al. Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses. Cell. 2021;184(1):106-119.</Citation></Reference><Reference><Citation>Wodrich H, Henaff D, Jammart B, et al. A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog. 2010;6(3):e1000808.</Citation></Reference><Reference><Citation>Blondot ML, Bruss V, Kann M. Intracellular transport and egress of hepatitis B virus. J Hepatol. 2016;64(1 suppl):S49-S59.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>